Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2018

Open Access 01-12-2018 | Research article

Mediation analysis to understand genetic relationships between habitual coffee intake and gout

Authors: Joseph Hutton, Tahzeeb Fatima, Tanya J. Major, Ruth Topless, Lisa K. Stamp, Tony R. Merriman, Nicola Dalbeth

Published in: Arthritis Research & Therapy | Issue 1/2018

Login to get access

Abstract

Background

Increased coffee intake is associated with reduced serum urate concentrations and lower risk of gout. Specific alleles of the GCKR, ABCG2, MLXIPL, and CYP1A2 genes have been associated with both reduced coffee intake and increased serum urate in separate genome-wide association studies (GWAS). The aim of this study was to determine whether these single nucleotide polymorphisms (SNPs) influence the risk of gout through their effects on coffee consumption.

Methods

This research was conducted using the UK Biobank Resource. Data were available for 130,966 European participants aged 40–69 years. Gout status and coffee intake were tested for association with four urate-associated SNPs: GCKR (rs1260326), ABCG2 (rs2231142), MLXIPL (rs1178977), and CYP1A2 (rs2472297). Multiple regression and path analysis were used to examine whether coffee consumption mediated the effect of the SNPs on gout risk.

Results

Coffee consumption was inversely associated with gout (multivariate adjusted odds ratio (95% confidence interval (CI)) for any coffee consumption 0.75 (0.67–0.84, P = 9 × 10−7)). There was also evidence of a dose-effect with multivariate adjusted odds ratio (95% CI) per cup consumed per day of 0.85 (0.82–0.87, P = 9 × 10−32). The urate-increasing GCKR, ABCG2, MLXIPL, and CYP1A2 alleles were associated with reduced daily coffee consumption, with the strongest associations for CYP1A2 (beta −0.30, P = 8 × 10−40), and MLXIPL (beta −0.17, P = 3 × 10−8), and weaker associations for GCKR (beta −0.07, P = 3 × 10−10) and ABCG2 (beta −0.09, P = 2 × 10−9). The urate-increasing GCKR and ABCG2 alleles were associated with gout (multivariate adjusted p < 5 × 10−8 for both), but the urate-increasing MLXIPL and CYP1A2 alleles were not. In mediation analysis, the direct effects of GCKR and ABCG2 accounted for most of the total effect on gout risk, with much smaller indirect effects mediated by coffee consumption.

Conclusion

Coffee consumption is inversely associated with risk of gout. Although alleles at several SNPs associate with both lower coffee consumption and higher risk of gout, these SNPs largely influence gout risk directly, rather than indirectly through effects on coffee consumption.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–54.CrossRefPubMed Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45(2):145–54.CrossRefPubMed
3.
go back to reference Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration. urate excretion and gout Nature genetics. 2008;40(4):437–42.CrossRefPubMed Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration. urate excretion and gout Nature genetics. 2008;40(4):437–42.CrossRefPubMed
4.
go back to reference Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. P Natl Acad Sci USA. 2009;106(25):10338–42.CrossRef Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. P Natl Acad Sci USA. 2009;106(25):10338–42.CrossRef
5.
go back to reference Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis research & therapy. 2015;17:98.CrossRef Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis research & therapy. 2015;17:98.CrossRef
6.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093–103.CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093–103.CrossRefPubMed
7.
go back to reference Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363(9417):1277–81.CrossRefPubMed Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363(9417):1277–81.CrossRefPubMed
8.
go back to reference Kela U, Vijayvargiya R, Trivedi CP. Inhibitory effects of methylxanthines on the activity of xanthine-oxidase. Life Sci. 1980;27(22):2109–19.CrossRefPubMed Kela U, Vijayvargiya R, Trivedi CP. Inhibitory effects of methylxanthines on the activity of xanthine-oxidase. Life Sci. 1980;27(22):2109–19.CrossRefPubMed
9.
go back to reference Kiyohara C, Kono S, Honjo S, Todoroki I, Sakurai Y, Nishiwaki M, et al. Inverse association between coffee drinking and serum uric acid concentrations in middle-aged Japanese males. Brit. J Nutr. 1999;82(2):125–30. Kiyohara C, Kono S, Honjo S, Todoroki I, Sakurai Y, Nishiwaki M, et al. Inverse association between coffee drinking and serum uric acid concentrations in middle-aged Japanese males. Brit. J Nutr. 1999;82(2):125–30.
10.
go back to reference Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third National Health and nutrition examination survey. Arthrit Rheum-Arthr. 2007;57(5):816–21.CrossRef Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third National Health and nutrition examination survey. Arthrit Rheum-Arthr. 2007;57(5):816–21.CrossRef
11.
go back to reference Zhang Y, Yang T, Zeng C, Wei J, Li H, Xiong YL, et al. Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis. BMJ Open. 2016;6(7):e009809.CrossRefPubMedPubMedCentral Zhang Y, Yang T, Zeng C, Wei J, Li H, Xiong YL, et al. Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis. BMJ Open. 2016;6(7):e009809.CrossRefPubMedPubMedCentral
12.
go back to reference Park KY, Kim HJ, Ahn HS, Kim SH, Park EJ, Yim SY, et al. Effects of coffee consumption on serum uric acid: systematic review and meta-analysis. Semin Arthritis Rheum. 2016;45(5):580–6.CrossRefPubMed Park KY, Kim HJ, Ahn HS, Kim SH, Park EJ, Yim SY, et al. Effects of coffee consumption on serum uric acid: systematic review and meta-analysis. Semin Arthritis Rheum. 2016;45(5):580–6.CrossRefPubMed
13.
go back to reference Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men—a prospective study. Arthritis Rheum. 2007;56(6):2049–55.CrossRefPubMed Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men—a prospective study. Arthritis Rheum. 2007;56(6):2049–55.CrossRefPubMed
15.
go back to reference Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140(1):1–8.CrossRefPubMed Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med. 2004;140(1):1–8.CrossRefPubMed
16.
go back to reference Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes. 2001;50(10):2349–54.CrossRefPubMed Greer F, Hudson R, Ross R, Graham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes. 2001;50(10):2349–54.CrossRefPubMed
17.
go back to reference Keijzers GB, De Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002;25(2):364–9.CrossRefPubMed Keijzers GB, De Galan BE, Tack CJ, Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002;25(2):364–9.CrossRefPubMed
18.
go back to reference Thong FSL, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol. 2002;92(6):2347–52.CrossRefPubMed Thong FSL, Graham TE. Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol. 2002;92(6):2347–52.CrossRefPubMed
19.
go back to reference van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes—a systematic review. J Am Med Assoc. 2005;294(1):97–104.CrossRef van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes—a systematic review. J Am Med Assoc. 2005;294(1):97–104.CrossRef
20.
go back to reference Petrie HJ, Chown SE, Belfie LM, Duncan AM, McLaren DH, Conquer JA, et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr. 2004;80(1):22–8.CrossRefPubMed Petrie HJ, Chown SE, Belfie LM, Duncan AM, McLaren DH, Conquer JA, et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr. 2004;80(1):22–8.CrossRefPubMed
21.
go back to reference Wu TY, Hankinson SE, Willett WC, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in US women. Diabetes Care. 2005;28(6):1390–6.CrossRefPubMed Wu TY, Hankinson SE, Willett WC, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in US women. Diabetes Care. 2005;28(6):1390–6.CrossRefPubMed
22.
go back to reference Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry. 2015;20(5):647–56.CrossRefPubMed Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry. 2015;20(5):647–56.CrossRefPubMed
23.
go back to reference Ollier W, Sprosen T, Peakman T. UK biobank: from concept to reality. Pharmacogenomics. 2005;6(6):639–46.CrossRefPubMed Ollier W, Sprosen T, Peakman T. UK biobank: from concept to reality. Pharmacogenomics. 2005;6(6):639–46.CrossRefPubMed
24.
go back to reference Collins R. UK biobank: protocol for a large-scale prospective epidemiological resource. In: Manchester: UK biobank coordinating Centre; 2007. Collins R. UK biobank: protocol for a large-scale prospective epidemiological resource. In: Manchester: UK biobank coordinating Centre; 2007.
25.
go back to reference Cadzow M, Merriman TR, Dalbeth N. Performance of gout definitions for genetic epidemiological studies: analysis of UK biobank. Arthritis Res Ther. 2017;19(1):181.CrossRefPubMedPubMedCentral Cadzow M, Merriman TR, Dalbeth N. Performance of gout definitions for genetic epidemiological studies: analysis of UK biobank. Arthritis Res Ther. 2017;19(1):181.CrossRefPubMedPubMedCentral
26.
go back to reference Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.CrossRef Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.CrossRef
27.
go back to reference Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.CrossRefPubMedPubMedCentral Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.CrossRefPubMedPubMedCentral
29.
go back to reference Perera V, Gross AS, McLachlan AJ. Measurement of CYP1A2 activity: a focus on caffeine as a probe. Curr Drug Metab. 2012;13(5):667–78.CrossRefPubMed Perera V, Gross AS, McLachlan AJ. Measurement of CYP1A2 activity: a focus on caffeine as a probe. Curr Drug Metab. 2012;13(5):667–78.CrossRefPubMed
30.
go back to reference Thorn CF, Aklillu E, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics. 2012;22(1):73–7.CrossRefPubMedPubMedCentral Thorn CF, Aklillu E, Klein TE, Altman RB. PharmGKB summary: very important pharmacogene information for CYP1A2. Pharmacogenet Genomics. 2012;22(1):73–7.CrossRefPubMedPubMedCentral
31.
go back to reference Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472–82.PubMed Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472–82.PubMed
32.
go back to reference Clarke TK AM, Davies G, Howard DM, Hall, LS, Padmanabhan S, Murray A, Smith B, Campbell A, Hayward C, Porteous D, Deary IJ, McIntosh AM. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK biobank (N=112,117). 2017. Clarke TK AM, Davies G, Howard DM, Hall, LS, Padmanabhan S, Murray A, Smith B, Campbell A, Hayward C, Porteous D, Deary IJ, McIntosh AM. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK biobank (N=112,117). 2017.
33.
go back to reference Rasheed H, Stamp LK, Dalbeth N, Merriman TR. Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Res Ther. 2017;19(1):161.CrossRefPubMedPubMedCentral Rasheed H, Stamp LK, Dalbeth N, Merriman TR. Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Res Ther. 2017;19(1):161.CrossRefPubMedPubMedCentral
35.
go back to reference Robinson PC, Choi HK, Do R, Merriman TR. Insight into rheumatological cause and effect through the use of Mendelian randomization. Nat Rev Rheumatol. 2017;13(3):193.CrossRefPubMed Robinson PC, Choi HK, Do R, Merriman TR. Insight into rheumatological cause and effect through the use of Mendelian randomization. Nat Rev Rheumatol. 2017;13(3):193.CrossRefPubMed
36.
go back to reference Galante J, Adamska L, Young A, Young H, Littlejohns TJ, Gallacher J, et al. The acceptability of repeat internet-based hybrid diet assessment of previous 24-h dietary intake: administration of the Oxford WebQ in UK biobank. Br J Nutr. 2016;115(4):681–6.CrossRefPubMed Galante J, Adamska L, Young A, Young H, Littlejohns TJ, Gallacher J, et al. The acceptability of repeat internet-based hybrid diet assessment of previous 24-h dietary intake: administration of the Oxford WebQ in UK biobank. Br J Nutr. 2016;115(4):681–6.CrossRefPubMed
Metadata
Title
Mediation analysis to understand genetic relationships between habitual coffee intake and gout
Authors
Joseph Hutton
Tahzeeb Fatima
Tanya J. Major
Ruth Topless
Lisa K. Stamp
Tony R. Merriman
Nicola Dalbeth
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2018
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-018-1629-5

Other articles of this Issue 1/2018

Arthritis Research & Therapy 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.